Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT04488822 |
| Consolidated Lead Sponsor | Daiichi Sankyo |
| Therapeutic Condition Cohort | Oncology and Hematology |
| Clinical Trial Phase | Phase III |
| Overall Recruitment Status | ACTIVE NOT RECRUITING |
| Registered Enrollment | 40 participants (ACTUAL) |
| Registered Start Date | 2020-09-25 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Peking University Cancer Hospital | Beijing, China | Open Hospital Dossier -> |
| The First Affiliated Hospital, Sun-Yat Sen University | Guangzhou, China | Open Hospital Dossier -> |
| The Second Affiliated Hospital of Zhejiang University School of Medicine | Hangzhou, China | Open Hospital Dossier -> |
| Zhejiang Cancer Hospital | Hangzhou, China | Open Hospital Dossier -> |
Related Filings Across Meru Platforms
Verified cross-ledger federal filings for Daiichi Sankyo across sibling Meru public-data platforms.
Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.